An increased production of nitric oxide (NO) via the inducible isoform of NO synthase (iNOS) has been incriminated in the pathogenesis of septic shock. Since the time course of iNOS activity is not known during endotoxic shock in dogs, we measured iNOS activity, estimated by the rate of conversion of 14 C-arginine to 14 C-citrulline in the absence of calcium, in the heart, lung, liver, kidney, and gut at 1, 2, 3, 4, and 6 h after a bolus of Escherichia coli endotoxin (2 mg/kg, iv), in the dog. This model, including generous fluid administration, is associated with typical features of human septic shock, including low systemic vascular resistance, altered myocardial function and limited oxygen extraction capability. An increase in iNOS activity was observed at 4 h in the liver (0.24 vs 0.04 mU/mg/ min) and at 6 h in the heart (0.26 vs 0.09 mU/mg/ min). These findings may contribute to a better delineation of the involvement of NO in endotoxic shock, and to the evaluation of the therapeutic effects of NO inhibitors.
Human septic shock is typically associated with severe hypotension, myocardial depression, and dysfunction of multiple organs. These features may be reproduced in animals by the administration of endotoxin followed by generous fluid administration. The magnitude and type of effects elicited by endotoxin may vary between species. In particular, rodents are more resistant than larger animals to the effects of endotoxin, so that the relevance of the findings in murine models to the human situation has been challenged (1) .
In rodents, the nitric oxide (NO) pathway seems to play a key role in the alterations of experimental endotoxic shock. Under these conditions, an overproduction of NO is triggered by endotoxin, mainly through the activation of inducible NO synthase (iNOS) (2) . In rodents, the administration of selective iNOS inhibitors prevents the deleterious cellular effects of NO during septic shock. The effects of these compounds may, however, differ between species. In larger species, including humans, the higher concentrations of several inflammatory mediators required to activate iNOS suggests that involvement of the NO pathway may be less important (3, 4) . In a dog model, enhancement of the hypertensive effect of arginine analog administration 2 to 4 h after endotoxin, suggested that an overproduction of NO is involved in the vascular alterations triggered by endotoxin (5) . In another dog model, however, arginine analogs exerted similar hemodynamic effects, in the presence and in the absence of endotoxin (6) . The present study was undertaken to define the kinetics of iNOS activity in a dog model of endotoxin shock. This model includes vigorous fluid therapy after a bolus of endotoxin, in order to mimic the clinical situation. It has been used to study the hemodynamic effects of various therapeutic interventions, including NO donors (7) and NOS inhibitors (8, 9) .
MATERIALS AND METHODS
This study was performed according to the guidelines of the Committee on the Care and Use of Laboratory Animals of the National Institute of Health/ American Heart Association.
Five adult male dogs (27 Ϯ 7 kgs) were anesthetized with pentobarbital (bolus of 25 mg/kg followed by a continuous infusion of 4 mg/kg/h), intubated, and mechanically ventilated. A venous catheter (16G, Abbott) was inserted in the right upper limb. The animals were given an intravenous bolus of Escherichia coli endotoxin (2 mg/kg, O55B5, Difco). Thirty minutes after endotoxin, normal saline was given and continued throughout the study (20 ml/ kg/h). The dogs were killed using a bolus of pentobarbital at 1, 2, 3, 4, and 6 h after the endotoxin bolus (n ϭ 1/time). In each dog, samples from the heart, lung, liver, kidney, and gut were rapidly removed and immediately stored in polypropylene tubes at Ϫ70°C.
iNOS activity was evaluated by the rate of conversion of [ 14 C]L-arginine into [ 14 C]L-citrulline, in the absence of calmodulin and calcium (10) . Unless otherwise specified, the reagents were purchased from Merck. After thawing, the samples were placed in a buffer solution (Tris-Hcl 50 mM, 0.1 mM ethylenediaminetetraacetate (EDTA), 0.1 mM ethyleneglycoltetraacetate (EGTA), mercaptoethanol 12 mM, and phenylmethylsulfonyl fluoride 1 mM) and homogenized. The total protein content of the samples was determined (BCA Protein Assay Reagent, Pierce). Thereafter, the samples (50 l) were incubated in the presence of 
Triton-X-100 (Sigma). A solution of [
14 C]L-arginine (500 M) was used as a standard. The results were expressed in mU/mg/min, with 1 mU corresponding to 1 nmol citrulline/mg protein/50 l.
RESULTS
The methodology used for the determination of iNOS activity was validated by the specificity of arginine in thin layer chromatography (10) .
There was no basal iNOS activity in any of the organs prior to endotoxin injection. iNOS activity, measured up to 3 h after endotoxin, was low in all organs. At 4 h after endotoxin, iNOS activity increased in the heart, lung, and liver and remained stable in the gut and kidney. The increase was largest in the liver and heart. At 6 h, the increased iNOS activity was still evident in the heart and the liver.
DISCUSSION
This study indicates that endotoxin shock in the dog is associated with an increase in iNOS activity, mainly in the liver and the heart, after 4 and 6 h. We only included one dog for each time interval. Since there was low iNOS activity in the tissue samples harvested up to three hours after endotoxin, we did not feel it was necessary to measure iNOS activity prior to endotoxin administration. iNOS activation is a complex process requiring gene transcription and posttranscriptional alterations which are unlikely to occur so early after endotoxin. The massive NO overproduction (presumably by the activated iNOS enzyme) should not occur immediately after a bolus of endotoxin, since in this model, the effects of N G -nitro-monomethyl-L-arginine (L-NMMA) were unaffected by the presence of endotoxin (9) . Ex vivo, mRNA for iNOS has been found from three hours after incubation with E. coli endotoxin (11). These observations suggest that NO produced locally by the activated iNOS may contribute to the organ dysfunction induced by endotoxin, including hepatic and myocardial dysfunction, consistent with the findings of Wolfard et al. (12) .
Compared with the methodology detecting mRNA for NOS, or with the pharmacological approach using L-arginine competitive analogs, the determination of NOS activity is a better reflection of NO production. Indeed, the determination of NOS activity can be influenced, like NO production, by posttranscriptional alterations and substrate availability.
Our findings differ from those reported in rodents. First, the magnitude of the increase in iNOS activity was larger in rats (amount of citrulline produced after endotoxin administration ranging from 2 to 50 pmol/min/mg protein). Second, the site of maximal iNOS activity was the lung in rats (13) , but the heart and the liver in the dog. Increase in dog lung iNOS activity has been reported 24 h after administration of 20 g/kg E. coli endotoxin (14) . The interspecies differences highlight the importance of differences in NO metabolism.
An increase in iNOS activity implies an increase in NO production, and may also imply an increase in superoxide generation. The ensuing peroxynitrite generation may actually be more deleterious than NO and superoxide separately (14) . The cellular toxic effects of iNOS-derived NO and peroxynitrite can contribute to the detrimental effects of endotoxin on tissue function. The present findings suggest that iNOS activation may be implicated in the hepatic and myocardial dysfunction of canine endotoxic shock.
